Related Experiment Video

Updated: May 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K

[PIK3CA mutations in the most common types of cancer]

Monika Anna Chomczyk1, Piotr Czajka2

  • 1Department of Clinical Molecular Biology, Medical University of Bialystok, 13 Waszyngtona St., 15-269 Białystok, Poland. m.chomczyk@wp.pl

Postepy Biochemii
|December 25, 2013
PubMed

Insights

Investigating PIK3CA mutations in common cancers offers new targeted therapy options. Understanding these mutations is key for effective cancer treatment and patient selection.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeted therapies are crucial for advancing cancer treatment.
  • The PI3K/PTEN/Akt pathway plays a significant role in carcinogenesis.
  • KRAS and PI3K are key proteins implicated in cancer development.

Purpose of the Study:

  • To provide an overview of PIK3CA mutations in common cancers within the PI3K/PTEN/Akt pathway.
  • To explore the potential of targeting key components of this pathway for novel cancer therapies.
  • To examine PIK3CA mutations as predictive factors for selecting targeted therapies.

Main Methods:

  • Literature review of scientific reports on PIK3CA mutations.
  • Analysis of the PI3K/PTEN/Akt pathway's role in carcinogenesis.
  • Examination of targeted therapy strategies.

Main Results:

  • PIK3CA mutations are common in various cancers and are part of the PI3K/PTEN/Akt pathway.
  • Targeting components of this pathway holds promise for developing new therapeutic approaches.
  • PIK3CA mutation status may serve as a biomarker for predicting treatment response.

Conclusions:

  • Targeting the PI3K/PTEN/Akt pathway, particularly through addressing PIK3CA mutations, is a promising strategy for cancer therapy.
  • Further research is needed to elucidate the structural and biochemical effects of various PIK3CA mutations on the p110a subunit.
  • Understanding PIK3CA gene function and its subunits is essential for complete discovery and therapeutic application.

More Related Videos

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.1K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

10.4K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K